Poland· PL-100406970
Sulpiryd Hasco
A sulpiride product containing sulpiridum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sulpiride is registered in 12 of 19 countries.
Countries holding a registration under ATC N05AL01 (sulpiride), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Sulpiride · ATC N05AL01
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of sulpiride costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $1.00 in France to $3.83 in Switzerland — a ×3.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sulpiride · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.83
- FR France$1.00
The record
At a glance
URPL (Poland)- Active substance
- Sulpiridum
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- N05AL01
- ATC class
- Sulpiride
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
1 priced- gtin0590999138041024 szt.PLN 6.31
- gtin05909991380427
- gtin05909991380434
- gtin05909991380441
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
23 interactions on record for sulpiride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulpiride · interactions on record
23 records
23 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Sulpiride in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandSulpiride Grindeks 100 mg tabletsAS Grindeks
- United KingdomDolmatil 200mg tabletsSanofi
- GermanyDogmatilNeuraxpharm Arzneimittel Gmbh
- CzechiaDOGMATILneuraxpharm Arzneimittel GmbH, Langenfeld
- BelgiumDogmatil 0,5 mg/100 mlSanofi Belgium
- FranceDOGMATIL 0,5 g/100 ml SANS SUCRE, solution buvable édulcorée au cyclamate de sodiumNEURAXPHARM FRANCE
- SpainDOGMATIL 50 mg/ml SOLUCION INYECTABLENeuraxpharm Spain S.L.U.
- NetherlandsDogmatil 400, tabletten 400 mgNeuraxpharm Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Dogmatil, Sulpirid Grindeks
- Belgium · Dogmatil, Sulpiride Eg
- Cyprus · Devodil, Sulpiren
- Czechia · Dogmatil, Prosulpin
- Germany · Dogmatil, Dogmatil Forte
- Estonia · Betamaks
- Spain · Dogmatil, Dogmatil Fuerte
- Finland · Suprium
- France · Dogmatil, Dogmatil Sans Sucre, Édulcorée Au Cyclamate De Sodium
- United Kingdom (Northern Ireland) · Sulpiride, Sulpiride Activase Pharmaceuticals
- Greece · Dogmatyl
- Croatia · Eglonyl, Eglonyl Forte
- Hungary · Depral
- Ireland · Dolmatil
- Italy · Dobren
- Lithuania · Eglonyl
- Luxembourg · Dogmatil, Sulpiride Eg
- Latvia · Betamaks
- Malta · Devodil, Sulpiride Grindeks
- Netherlands · Dogmatil
- Portugal · Dogmatil, Dogmatil Forte
- Romania · Eglonyl
- Slovenia · Eglonyl
- Slovakia · Betamaks, Sulpirid Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6cf496aa-80ab-46cb-8e2f-df72602aef01 GET /v1/drugs/6cf496aa-80ab-46cb-8e2f-df72602aef01?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "100 mg",
"packaging": "05909991380410 ¦ Rp ¦ 129163\n24 tabl.\n05909991380427 ¦ Rp ¦ 129164\n30 tabl.\n05909991380434 ¦ Rp ¦ 129165\n60 tabl.\n05909991380441 ¦ Rp ¦ 129166\n120 tabl.",
"substance": "Sulpiridum 100 mg",
"common_name": "Sulpiridum",
"pl_product_id": "100406970",
"pozwolenie_nr": "24866",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about sulpiride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.